Podcasts about early detection

EPISODE DESCRIPTIONRebecca V. Nellis never meant to run a nonprofit. She just never left. Twenty years later, she's still helming Cancer and Careers after a Craigslist maternity-leave temp job turned into a lifelong mission.In this 60-minute doubleheader, we cover everything from theater nerdom and improv rules for surviving bureaucracy, to hanging up on Jon Bon Jovi, to navigating cancer while working—or working while surviving cancer. Same thing.Rebecca's path is part Second City, part Prague hostel, part Upper East Side grant writer, and somehow all of that makes perfect sense. She breaks down how theater kids become nonprofit lifers, how “sample sale feminism” helped shape a cancer rights org, and how you know when the work is finally worth staying for.Also: Cleavon Little. Tap Dance Kid. 42 countries. And one extremely awkward moment involving a room full of women's handbags and one very confused Matthew.If you've ever had to hide your diagnosis to keep a job—or wanted to burn the whole HR system down—this one's for you.RELATED LINKSCancer and CareersRebecca Nellis on LinkedIn2024 Cancer and Careers Research ReportWorking with Cancer Pledge (Publicis)CEW FoundationI'm Not Rappaport – Broadway InfoFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship opportunities, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Guest: Jennifer Kistler, Breast Cancer Survivor & Healthcare ProfessionalHost: Jamie PrestonTopic: The importance of early detection and the emotional resilience of surviving breast cancerDiscussion Highlights:Life before diagnosis and how unexpected the news wasThe moment she heard the words, “You have breast cancer”Building a strong core of support during treatmentFinding friendship and purpose through shared experienceThe symbolism of ringing the bell and what it truly meansHow her perspective on health and strength has evolvedWhy every woman — even those without symptoms or family history — must prioritize screening www.YourHealth.Org

Clarence Ford speaks to Dr Fatima Hoosain, a Cape Town surgeon with a special interest in breast and thyroid health, about how cultural stigmas and myths (from witchcraft to taboo) are preventing South African women from seeking timely breast cancer screening and treatment. She explains the importance of breast self-examination, early detection, and community education in turning the tide against preventable deaths. Views and News with Clarence Ford is the mid-morning show on CapeTalk. This 3-hour long programme shares and reflects a broad array of perspectives. It is inspirational, passionate and positive. Host Clarence Ford’s gentle curiosity and dapper demeanour leave listeners feeling motivated and empowered. Known for his love of jazz and golf, Clarrie covers a range of themes including relationships, heritage and philosophy. Popular segments include Barbs’ Wire at 9:30am (Mon-Thurs) and The Naked Scientist at 9:30 on Fridays. Thank you for listening to a podcast from Views & News with Clarence Ford Listen live on Primedia+ weekdays between 09:00 and 12:00 (SA Time) to Views and News with Clarence Ford broadcast on CapeTalk https://buff.ly/NnFM3Nk For more from the show go to https://buff.ly/erjiQj2 or find all the catch-up podcasts here https://buff.ly/BdpaXRn Subscribe to the CapeTalk Daily and Weekly Newsletters https://buff.ly/sbvVZD5 Follow us on social media: CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567See omnystudio.com/listener for privacy information.

In this powerful solo episode, Ffion is joined by Carys Allen, Lead Nurse Specialist with Cervical Screening Wales, and Georgina Wren, a cervical cancer survivor, for an open and honest discussion about everything to do with cervical screening and cervical cancer.Together, they explore what actually happens during a smear test, what HPV is and why it matters, and the reasons so many people still feel nervous or avoid attending their screenings. Georgina bravely shares her personal story of discovering she had cervical cancer following her first smear test — a reminder of just how life-saving early detection can be.This episode tackles the taboos, fears, and misconceptions surrounding cervical screening, offering clarity, compassion, and reassurance that there is truly nothing to be afraid of.Honest, informative, and empowering — this is a must-listen for anyone wanting to understand cervical health and the importance of regular screening.Click the follow button to stay up to date on the latest episodes, and leave us a 5 star review!And remember… to keep saying it how it is!Cervical Screening Wales https://phw.nhs.wales/services-and-teams/screening/cervical-screening-wales/ Instagram:@sayithowitisspodcast - https://instagram.com/sayithowitisspodcast?igshid=MzRlODBiNWFlZA==@ffionalicelewis - https://instagram.com/ffionalicelewis?igshid=MzRlODBiNWFlZA==@georgia.wren - https://www.instagram.com/georgina.wren/?hl=en TikTok:sayithowitiss - https://www.tiktok.com/@sayithowitisss?_t=8gcJlLFHuPg&_r=1ffionalicelewis - https://www.tiktok.com/@ffionalicelewis?_t=8gcJsxoYsAi&_r=1 Hosted on Acast. See acast.com/privacy for more information.

In this episode of Taking Healthcare by Storm, Quality Insights Medical Director Dr. Jean Storm speaks with Laura Makaroff, DO, a family physician and Senior Vice President of Prevention and Early Detection at the American Cancer Society.Dr. Makaroff discusses her journey to the American Cancer Society and the organization's launch of CancerRisk360™, a personalized cancer risk assessment tool. She emphasizes the critical importance of early cancer detection, addressing disparities, and the role of modifiable risk factors in reducing cancer incidence and mortality.If you have any topics or guests you'd like to see on future episodes, reach out to us on our website.Publication number QI-102425-GK

In this special live episode of the SHE MD Podcast, Olivia Munn joins Dr. Thaïs Aliabadi, Mary Alice Haney, Dr. Shari Goldfarb, and Kristen Dahlgren, for a powerful Breast Cancer Awareness Month panel in New York City. The event coincided with NBC's Today Show coverage and the lighting of the Empire State Building in pink — marking the launch of a national conversation around early detection, AI, and prevention.Together, they explore how lifetime risk assessments, dense breast screening, and AI mammogram prediction tools like Clarity Breast are transforming breast health. The panel also discusses cancer vaccine research, genetic testing, and the importance of women knowing their individual risk scores.Listeners will hear Olivia's personal story of early detection after a high-risk score prompted further imaging, leading to her diagnosis and recovery. This episode offers clarity, action, and hope — empowering every listener to become their own health advocate and partner with their medical team.Subscribe to SHE MD Podcast for expert tips on PCOS, Endometriosis, fertility, and hormonal balance. Share with friends and visit the SHE MD website and Ovii for research-backed resources, holistic health strategies, and expert guidance on women's health and well-being.What You'll LearnHow lifetime risk assessment tools can identify breast cancer risk before symptoms appearWhy dense breast tissue requires supplemental screening beyond mammogramsHow AI predictive tools like Clarity Breast are revolutionizing early detectionThe promise of vaccine research and genetic testing in future breast cancer preventionKey Timestamps(00:00) Live event intro and Breast Cancer Awareness Month context(03:30) Olivia's story: risk score, MRI findings, and early diagnosis(13:00) Dr. Aliabadi and Dr. Goldfarb on dense breast screening and AI tools(16:00) Cancer vaccine and immunotherapy discussion with Kristen Dahlgren(27:00) Genetic testing and family history: understanding your risk(34:00) Audience Q&A: emotional recovery and advocacy(42:00) Is there support for young women being diagnosed with breast cancer?(51:30) Clarifying the term Risk AssessmentKey TakeawaysEvery woman should know her lifetime breast cancer risk scoreDense breasts may obscure cancers — MRI and ultrasound can save livesAI mammogram tools are changing detection from reactive to predictiveResearch into cancer vaccines offers hope for prevention and recurrence reductionAdvocacy and awareness remain key — early action leads to better outcomesGuest BiosOlivia MunnOlivia Munn is an actress, health advocate, and breast cancer survivor. After receiving a high lifetime risk assessment score, she underwent further imaging that revealed cancer across multiple quadrants, leading to a bilateral mastectomy. Since publicly sharing her diagnosis in 2024, she has dedicated her platform toward raising awareness about early detection, risk assessment, and empowering women with knowledge about their breast health.Dr. Shari Goldfarb, MDDr. Shari Goldfarb is a breast medical oncologist at Memorial Sloan Kettering, with a clinical focus on early and advanced breast cancer. Her research centers on survivorship, symptom management, fertility, sexual health, and quality of life for breast cancer patients. She participates in clinical trials aimed at improving outcomes for women during and after treatment.Kristen DahlgrenKristen Dahlgren is a former NBC correspondent who, after her own stage 2 breast cancer diagnosis, left journalism to found the Cancer Vaccine Coalition. She collaborates with top cancer centers to accelerate immunotherapy and vaccine development in breast cancer and advocates for preventive strategies beyond current standards.LinksOlivia Munn – https://www.instagram.com/oliviamunnDr. Shari Goldfarb – https://www.mskcc.org/profile/shari-goldfarbKristen Dahlgren – https://www.linkedin.com/in/kristen-dahlgren-886519292/Donna McKay – https://www.bcrf.org/teamResources MentionedBreast Cancer Research Foundation (BCRF) – Funding for innovative breast cancer research and prevention programs

In this episode of Longevity by Design, host Gil Blander sits down with Florence Comite, MD, physician-scientist and founder of the Comite Center for Precision Medicine & Healthy Longevity. They explore why a one-size-fits-all approach to longevity falls short and how personalized data, from biomarkers to genetics, can spot early signs of disease before symptoms appear.Florence explains her “Nof1” method, which uses deep testing, wearables, and personal history to craft precise health plans. She highlights how sleep, more than exercise or diet, shapes long-term health but remains hard for most people to optimize. Using real-world examples, Florence shows why tracking markers like insulin and hormones matter, and why most people need support to turn health knowledge into action.The conversation covers the limits of standard medical care, the value of knowing your family history, and how even the best routines must adapt over time. Florence urges listeners to get curious about their own data and take steps—however small—toward better health.Guest-at-a-Glance 

This life-saving conversation is for anyone who has—or loves someone who has—breasts. It's what to look for, what to ask, what screenings you *actually need* (not just what is offered), and every decision point you have (even if it's not offered to you) if you are facing surgery.   This Breast Cancer Awareness Month, Glennon, Abby, and Amanda empower us with the most vital tool we have: information. Amanda reflects on how self-advocacy led her to her own breast cancer diagnosis—and we hear from the pod squad about how Amanda's transparency helped save their lives. Then, we're joined by Amanda's renowned doctor, Dr. Lucy M. De La Cruz, who reminds us that every patient has agency—and shares how to choose the treatment path that's right for you. And special shout out and thanks to Pod Squader Lori Mihalich-Levin (@mindfulreturn) for being such a special part of this story! If you or someone you love has been diagnosed with breast cancer, please save this episode or send it to the people you love. We love you.  For more on Amanda's Breast Cancer journey:  - Amanda's Diagnosis and What's Next (Part 1) - Amanda's Diagnosis and What's Next (Part 2) - Amanda Returns Post Surgery: Here's What She Wants You to Know  - What Amanda's Learned About Life, Love & Community (Post Surgery Pt 2)  - Early Detection, Mammograms & Breast Cancer Care with Dr. Rachel Brem  - Expert Advice on Genetic Testing, Cancer Prevention & Care Disparities with Dr. Rachel Brem  About Dr. De La Cruz:  Dr. Lucy M. De La Cruz is an internationally recognized breast surgical oncologist and the youngest Latina Chief of Breast Surgery in an academic institution in the United States. She serves as Chief of Breast Surgery and Director of the Betty Lou Ourisman Breast Health Center at MedStar Georgetown University Hospital, a nationally ranked center of excellence in breast cancer care. Dr. De La Cruz specializes in nipple-sparing mastectomies with structural preservation and resensation, with a focus on highly specialized single-stage implant reconstruction. Patients describe her not only as a world-class surgeon, but as a fierce advocate and mentor—especially for women navigating the complexities of diagnosis, treatment, and survivorship. 

Sally Wolf is back in the studio and this time we left cancer at the door. She turned 50, brought a 1993 Newsday valedictorian article as a prop, and sat down with me for a half hour of pure Gen X therapy. We dug into VHS tracking, Red Dawn paranoia, Michael J. Fox, Bette Midler, and how growing up with no helmets and playgrounds built over concrete somehow didn't kill us.We laughed about being Jewish kids in the suburbs, the crushes we had on thirty-year-olds playing teenagers, and what it means to hit 50 with your humor intact. This episode is part nostalgia trip, part roast of our own generation, and part meditation on the privilege of being alive long enough to look back at it all. If you ever watched Different Strokes “very special episodes” or had a Family Ties lunchbox, this one's for you.RELATED LINKSSally Wolf Official WebsiteSally Wolf on LinkedInSally Wolf on InstagramCosmopolitan Essay: “What It's Like to Have the ‘Good' Cancer”Oprah Daily: “Five Things I Wish Everyone Understood About My Metastatic Breast Cancer Diagnosis”Allure Breast Cancer Photo ShootTom Wilson's “Stop Asking Me the Question” SongFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

This episode is sponsored by IDEXX This podcast episode, hosted by Adam Christman, DVM, MBA, features oncologists Dana Connell, DVM, MPH, DACVIM (Oncology) and Zachary L. Neumann, DVM, MS, DACVIM (Oncology), discussing the significance of early cancer detection in dogs. The conversation focuses on the IDEXX Cancer Dx testing. The doctors explain how the test, which can be included in routine wellness exams, provides rapid results, enabling veterinarians to make timely diagnoses and improve treatment outcomes. They also touch on the importance of the veterinary team in communicating sensitive news to pet owners and the future potential of the test to screen for other types of cancer.

October means it's time to talk boob health!

In this episode, David Harding, Senior Vice President of Pipeline Product Management at Exact Sciences, discusses a new survey of healthcare executives on multi-cancer early detection. He shares insights on system readiness, patient demand, and the barriers health systems face in adopting this transformative approach to cancer screening.This episode is sponsored by Exact Sciences.

Dr. Nikki Maphis didn't just lose a grant. She lost a lifeline. An early-career Alzheimer's researcher driven by her grandmother's diagnosis, Nikki poured years into her work—only to watch it vanish when the NIH's MOSAIC program got axed overnight. Her application wasn't rejected. It was deleted. No feedback. No score. Just gone.In this episode, Oliver Bogler pulls back the curtain on what happens when politics and science collide and promising scientists get crushed in the crossfire. Nikki shares how she's fighting to stay in the field, teaching the next generation, and rewriting her grant for a world where even the word “diversity” can get you blacklisted. The conversation is raw, human, and maddening—a reminder that the real “war on science” doesn't happen in labs. It happens in inboxes.RELATED LINKS:• Dr. Nikki Maphis LinkedIn page• Dr. Nikki Maphis' page at the University of New Mexico• Vanguard News Group coverage• Nature article• PNAS: Contribution of NIH funding to new drug approvals 2010–2016FEEDBACK:Like this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, visit outofpatients.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

David Harding, senior vice president, pipeline product management at Exact Sciences, joins HealthLeaders for a discussion on how to help health system leaders understand the foundation of Multi-Cancer Early Detection (MCED) and how it can impact cancer diagnosis, drive innovation and improve patient outcomes. Information presented is not clinical, diagnostic, or treatment advice for any particular patient. Providers should use their clinical judgement and experience when deciding how to diagnose or treat patients. Exact Sciences does not recommend or endorse any particular course of treatment or medical choice.

Carla Tardiff has spent 17 years as the CEO of Family Reach, a nonprofit that shouldn't have to exist but absolutely does—because in America, cancer comes with a price tag your insurance doesn't cover.We talk about shame, fear, burnout, Wegmans, Syracuse, celebrity telethons, and the godforsaken reality of choosing between food and treatment. Carla's a lifer in this fight, holding the line between humanity and bureaucracy, between data and decency. She's also sharp as hell, deeply funny, and more purpose-driven than half of Congress on a good day.This episode is about the work no one wants to do, the stuff no one wants to say, and why staying angry might be the only way to stay sane.Come for the laughs. Stay for the rage. And find out why Family Reach is the only adult in the room.RELATED LINKSFamily ReachFinancial Resource CenterCarla on LinkedInMorgridge Foundation ProfileAuthority Magazine InterviewSyracuse University FeatureFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Connect with us via text! Sit down with our managing editor to get the dish on this DERMASCOPE's October. Hear about the "Working Together to Fight Skin Cancer: Education, Prevention, & Early Detection" webinar on October 20, the October issue with a beautiful cover featuring Face Reality Skincare, and an exclusive giveaway on DERMASCOPE's Instagram! As always, check the links below to learn more about anything you heard in this episode! Follow DERMASCOPE:Instagram: @dermascopeFacebook: facebook.com/dermascopePinterest: @dermascopeTikTok: @dermascopeAdditional Links:Visit our website.Learn more about this podcast.Subscribe to the magazine.Read the October 2025 issue. Get an anniversary box.Register for the October 20 webinar.

In this episode of Confessions of a Male Gynecologist, Dr. Shawn Tassone explores the vital connection between hormone health and breast cancer screening. Drawing from his best-selling book The Hormone Balance Bible, he breaks down the most common screening methods — mammography, ultrasound, and thermography — and explains how each one works, their benefits, and their limitations. Dr. Tassone also discusses emerging imaging technologies, like the QT scan, and emphasizes why understanding your options is key to prevention and peace of mind. Whether you're curious about alternative testing methods or looking to make informed choices about your breast health, this episode empowers women with knowledge to take charge of their own care. Episode Highlights: Key takeaways from The Hormone Balance Bible on hormone imbalances and overall wellness The differences between mammography, ultrasound, and thermography in breast cancer screening Why thermography is a physiological test, while mammography and ultrasound focus on structure The pros and cons of each screening method — and why no single test is perfect How ultrasound can sometimes catch what mammograms miss The lower false-positive rate associated with thermography The promise of emerging imaging technologies like the QT scan Why prevention is more powerful than detection in the fight against cancer How to choose the breast screening method that aligns best with your health goals and comfort level Episode Resources: Dr. Shawn Tassone's Practice | Tassone Advanced Gynecology Dr. Shawn Tassone's Book | The Hormone Balance Bible Dr. Shawn Tassone's Integrative Hormonal Mapping System | Hormonal Archetype Quiz Medical Disclaimer This podcast and website represent the opinions of Dr. Shawn Tassone and his guests. The content here should not be taken as medical advice and is for informational purposes only. Because each person is so unique, please consult your health care professional for any medical questions.

DianeKazer.com/PATIENT DianeKazer.com/RESOURCES DianeKazer.com/EXPLANTSOLUTION DianeKazer.com/PEPTIDEPOWER DianeKazer.com/SHOP DianeKazer.com/VIP DianeKazer.com/PURCHASEPEPTIDES DianeKazer.com/PURCHASEPEPTIDESVIP For decades, we've trusted the message: Catch it early, save your life. But what if the very tools built for “early detection” — mammograms, MRIs and scans — are exposing us to radiation, inflammation, and fear that may actually fuel disease instead of prevent it? This week's episode dismantles the myth of modern cancer screening — and uncovers a deeper truth about what really drives healing and prevention.

Jennifer J. Brown is a scientist, a writer, and a mother who never got the luxury of separating those roles. Her memoir When the Baby Is Not OK: Hopes & Genes is a punch to the gut of polite society and a medical system that expects parents to smile through trauma. She wrote it because she had to. Because the people who gave her the diagnosis didn't give her the truth. Because a Harvard-educated geneticist with two daughters born with PKU still couldn't get a straight answer from the very system she trained in.We sat down in the studio to talk about the unbearable loneliness of rare disease parenting, the disconnect between medical knowledge and human connection, and what it means to weaponize science against silence. She talks about bias in the NICU, the failure of healthcare communication, and why “resilience” is a lazy word. Her daughters are grown now. One's a playwright. One's an artist. And Jennifer is still raising hell.This is a conversation about control, trauma, survival, and rewriting the script when the world hands you someone else's lines.Bring tissues. Then bring receipts.RELATED LINKS• When the Baby Is Not OK (Book)• Jennifer's Website• Jennifer on LinkedInFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, visit outofpatients.show.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Breast cancer awareness, early detection, mammograms, and modern treatment options—learn what women 40+ need to know now. In this Breast Cancer Awareness Month special, we talk breast cancer signs, risk factors, and how early detection saves lives. Dr. Elizabeth O'Leary—breast surgeon and head of Lady Slipper Breast Center—shares practical guidance on breast cancer screening, genetics, lifestyle, and survivorship. If you've delayed your mammogram, this conversation is your nudge. We cover what's changed in breast cancer care, what to ask your providers, and how to advocate for yourself with confidence.Timestamps(00:00) Introduction to Breast Cancer Awareness Month & why this episode matters(02:05) Meet Dr. Elizabeth O'Leary: training, Johns Hopkins, and founding Lady Slipper Breast Center(06:18) Patient-first care: time, personalization, and thriving after treatment(10:40) Lisa's breast cancer story: fear, surgery decisions, and believing for a cure(15:22) Early detection essentials: mammograms, dense breasts, and screening timelines(19:30) High-risk assessment at 25: who needs early imaging and why it matters(24:05) Genetics 101: family history, moving-target panels, and what results mean(28:48) Lifestyle factors: diet, exercise, stress, alcohol—what the research supports(34:12) Advocacy & self-trust: how to speak up and choose your care team(37:20) Hope & next steps: practical actions to take this week(39:15) Where to find Dr. O'Leary & Lady Slipper Breast CenterKey TakeawaysEarly detection saves lives. Annual mammograms (and MRI for select high-risk women) dramatically improve outcomes.High-risk assessment should start at 25. A formal risk review can identify women who need earlier or additional screening.Genetics is evolving. “Negative before” doesn't always mean negative now—panels and insights continue to expand.Lifestyle matters. Consistent movement, strength training, weight management, stress reduction, and limiting alcohol are linked to lower risk.You can be both calm and proactive. Ask questions, understand your options, and choose a team that treats the whole person.Guest BioDr. Elizabeth O'Leary, MD is a breast surgeon and founder of Lady Slipper Breast Center in Minnesota (St. Paul, St. Louis Park, Edina). Trained at the University of Minnesota and Johns Hopkins, she specializes in personalized, comprehensive breast care—from screening and diagnosis through treatment and survivorship—with a focus on early detection, minimally invasive approaches, and patient-centered outcomes.Resource LinksLady Slipper Breast Center (Dr. Elizabeth O'Leary): https://www.elizabetholearymd.comFind a high-risk breast clinic near you (search “breast cancer high risk clinic” + your city)Breast density info & screening options (ask your imaging center about tomosynthesis and MRI for high-risk patients)Lifestyle tools: activity trackers, strength programs for women 40+, and stress-reduction practices (breathwork, prayer, therapy)Tags/Keywordsbreast cancer awareness, breast cancer, early detection, mammogram,...

Confronting Cancer: Insights on Prevention, Early Detection & Treatment by Capital FM

Breast Cancer Awareness Month reminds us: early detection saves lives.

In honor of Breast Cancer Awareness Month, this episode of Docs in a Pod features Kimberly Channels, PA-C, from WellMed in New Tampa. Hosts Ron Aaron and Dr. Tamika Perry from WellMed at Redbird Square lead a powerful conversation about early detection, risk factors, and the importance of regular screenings. Docs in a Pod focuses on health issues affecting adults. Clinicians and other health partners discuss stories, topics and tips to help you live healthier. Docs in a Pod airs on Saturdays in the following cities:  7:00 to 7:30 am CT:  San Antonio (930 AM The Answer)  DFW (660 AM, 92.9 FM [Dallas], 95.5 FM [Arlington], 99.9 FM [Fort Worth])  6:30 to 7:00 pm CT:  Houston (1070 AM/103.3 FM The Answer)  7:00 to 7:30 pm CT:  Austin (KLBJ 590 AM/99.7 FM)  Docs in a Pod also airs on Sundays in the following cities:  1:00-1:30 pm ET:  Tampa (860 AM/93.7FM) 

Send us a textCan your dentist use artificial intelligence (AI) to spot health problems sooner? Imagine an extra set of eyes that never gets tired — that's what AI is bringing to dentistry. In this episode, Ahmed Sultan, BDS, PhD, director of the Division of Artificial Intelligence Research at the University of Maryland School of Dentistry, shares how new AI tools are helping dentists catch issues like cavities and oral cancer earlier. He also talks about why it matters to use diverse data, the ethical questions behind AI in health care, and how these advances could especially benefit people in rural and low-income communities.Tune in to discover how AI is shaping the future of dental visits — and maybe even protecting more than just your smile.Learn more about AI research at the University of Maryland School of Dentistry at https://www.dental.umaryland.edu/ai/Listen to The UMB Pulse on Apple, Spotify, Amazon Music, and wherever you like to listen. The UMB Pulse is also now on YouTube.Visit our website at umaryland.edu/pulse or email us at umbpulse@umaryland.edu.

This episode of Standard Deviation features Oliver Bogler in conversation with Dr Na Zhao, a cancer biologist caught in the crossfire of science, politics, and survival. Na's life reads like a brutal lab experiment in persistence.She grew up in China, lost her mother and aunt to breast cancer before she turned twelve, then came to the United States to chase science as both an immigrant and a survivor's daughter. She worked two decades to reach the brink of independence as a cancer researcher, only to watch offers and grants vanish in the political chaos of 2025.Oliver brings her story into sharp focus, tracing the impossible climb toward a tenure-track position and the human cost of a system that pulls the ladder up just as people like Na reach for it. This conversation pulls back the curtain on the NIH funding crisis, the toll on early-career scientists, and what happens when personal tragedy fuels professional ambition.Listeners will walk away with a raw sense of how fragile the future of cancer research really is, and why people like Na refuse to stop climbing.RELATED LINKSDr Zhao at Baylor College of MedicineDr Zhao on LinkedInDr Zhao's Science articleIndirect Costs explained by US CongressFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

How do you respond when a friend faces a diagnosis that changes everything? What does real support look like during breast cancer treatment? In this episode, you’ll hear how friendship, early detection, and self-advocacy made a difference. You’ll also learn about the challenges of treatment, the role of caregivers, and ways communities rally when it’s needed most. Discover what it takes to face fear and make critical decisions. Hear two friends describe finding strength and asking for help. See why early action and support networks can impact recovery. Key Questions Answered How did Anne-Laure discover her breast cancer? How old was Anne-Laure when she was diagnosed with breast cancer? What was Anne-Laure’s experience with her initial diagnosis? How did Anne-Laure finally receive an accurate diagnosis? What type of breast cancer was Anne-Laure diagnosed with? How soon after diagnosis did Anne-Laure begin treatment? Did Ann-Laure use cold caps to try to keep her hair during chemotherapy? What was the role of friends and support in Anne-Laure’s journey? How did Anne-Laure and her husband communicate about her diagnosis and treatment? How did Anne-Laure handle the emotional impact and fear during her breast cancer journey? How did Anne-Laure and Rochelle support each other as friends through the process? What advice does Anne-Laure offer about early detection and self-advocacy? How did the experience change Anne-Laure’s approach to accepting help? How did Anne-Laure process and talk to herself through her treatment? How did Anne-Laure and her community celebrate treatment milestones? Timestamped Overview 00:00 Self-Discovery of Unusual Growth 03:25 Considering a Second Opinion 09:06 "Princess Diana's Influence on Cold Caps" 11:23 Hair Perception and Dry Ice Delivery 15:52 Hospital Freezers: Aiding Neuropathy Treatment 17:00 Finding Humor in Cold Caps 22:59 "Embracing Limits and Early Detection" 24:01 Early Detection Saved My Life 29:25 "Caregiver Struggles and Attention" 32:07 Support Network Eases Transition 35:37 Proactive Help and Support 38:20 Overcoming Fear Through Understanding Support The Rose HERE. Subscribe to Let’s Talk About Your Breasts on Apple Podcasts, Spotify, iHeart, and wherever you get your podcasts.See omnystudio.com/listener for privacy information.

Dr. Monty Pal and Dr. Matteo Lambertini discuss a compelling global study on the clinical behavior of breast cancer in young BRCA1 and BRCA2 carriers, the association of pre-diagnostic awareness of BRCA status with prognosis, and the importance of identifying healthy people who are at risk of carrying the BRCA1/2 pathogenic variants. TRANSCRIPT Dr. Monty Pal: Well, hello everyone, and welcome to the ASCO Daily News Podcast. I'm your host, Dr. Monty Pal. I'm a medical oncologist, professor, and vice chair of medical oncology at the City of Hope Comprehensive Cancer Center in Los Angeles. Now, when we think about genetic testing, whether for patients diagnosed with breast cancer or for other family members of them, it seems to be widely underutilized. Today, we're going to be discussing a recently published study in the Journal of Clinical Oncology that reported on the clinical behavior of breast cancer and specifically young BRCA1 and BRCA2 carriers, and the association of pre-diagnostic awareness of BRCA status with prognosis. I thought this was just a fascinating piece, and I honestly couldn't wait to have this conversation. It's a really compelling paper that highlights the importance of identifying healthy people who are at risk of carrying the BRCA1/2 pathogenic variants, and really the need for genetic counseling and testing to inform people about early detection that could lead to a better prognosis. I'm really delighted to welcome the study's lead author, Dr. Matteo Lambertini. He really needs no introduction. He's very well known in the breast cancer world for his amazing contributions to fertility in the context of breast cancer, to pregnancy in the context of breast cancer, and genetic testing. He's an associate professor at the University of Genova, and a breast cancer medical oncologist at the San Martino Polyclinic Hospital in Genova, Italy.  Dr. Lambertini, thank you so much for joining us today. Dr. Matteo Lambertini: Thank you very much, Dr. Pal. It's a great pleasure. Dr. Monty Pal: Oh, thanks. And just FYI, if you're listening in and you want to hear our disclosures, they're all listed at the transcript of this podcast.  So, I poured through this paper [Clinical Behavior of Breast Cancer in Young BRCA Carriers and Prediagnostic Awareness of Germline BRCA Status] yesterday, Dr. Lambertini, and first of all, congratulations on this study. This was a huge international multicenter effort, 4,752 patients. How did you pool all these patients with young breast cancer? Dr. Matteo Lambertini: Thanks a lot for the question. Yes, this was an effort made by several centers all over the world. The main idea behind the creation of this network that we have named as BRCA BCY Collaboration, was to get as many data as possible in a sort of niche patient population in the breast cancer field, meaning women diagnosed with breast cancer at the age of 40 years or younger, and all of them being BRCA carriers. We know that around, in the Western world, around 5% of breast cancer cases are being diagnosed under the age of 40 years, and among them around 10-15% are BRCA carriers. So, I would say it's a relatively rare patient population where we did not have a lot of evidence to support our choices in terms of counseling on treatment, prevention, and oncofertility as well. That was the idea behind the creation of this network that includes many centers. Dr. Monty Pal: Yeah. You know, what's so interesting about this is that you sort of draw this line between patients who have BRCA testing at the time of diagnosis and then BRCA testing earlier in their course and then leading to a diagnosis perhaps. And I think that's where really sort of the dichotomy in outcome sits. Can you maybe elaborate on this and tell us about timing of genetic testing in this study and what that meant ultimately in terms of prognosis? Dr. Matteo Lambertini: In this specific analysis from this large network, including almost 5,000 women with breast cancer diagnosed at the age of 40 years or younger and being a BRCA carrier, we looked specifically into the timing of genetic testing because this is a retrospective study and the criteria for inclusion are those that I have just mentioned, so diagnosis at a young age plus carrying germline BRCA pathogenic or likely pathogenic variant. In this analysis, we have looked into the time the patient has got the genetic testing and particular we focused on two populations: those that were diagnosed, knowing already to be a BRCA carrier, and those that got tested after being diagnosed with breast cancer. And the main findings from this analysis have been that knowing to be a BRCA carrier was associated with a lower stage at the time of diagnosis, meaning more T1 tumors, so a tumor less than 2 cm, more node-negative disease, and this translated into less aggressive treatment, so less often axillary dissection, less often use of chemotherapy and anthracycline-based chemotherapy. And even more importantly, we have seen a better overall survival for those patients that were diagnosed already knowing to be BRCA carriers as compared to those tested after breast cancer diagnosis. These results after adjusting for all the confounding, stage, treatment and so on, there was not significant anymore, meaning that it's not the timing of test per se that is probably leading to a better survival, but it is the fact that knowing to be a BRCA carrier would likely translate into having access to all the preventive measures that we have in this setting and this will translate into an overall survival benefit, so in terms of saving more lives in young BRCA carriers. Dr. Monty Pal: I think it's such an important point, and it's one that I think might sound implicit, right, but it needs to be proven, I think, through a study like this. You know, the fact that finding this early, identifying the mutation, doing enhanced screening, and so forth, is really going to lead to superior clinical outcomes. One of the things that I think many people puzzle over, including myself, is what to do? I personally occasionally will see BRCA altered patients in the context of prostate cancer. But that's a very different population of individuals, right? Typically older men. In young females with BRCA mutation, I guess there's a specific set of considerations around reproductive health. You'd already highlighted preventive strategies, but what sorts of things should we be talking about in the clinics once a patient's diagnosed and once perhaps their breast cancer diagnosis is established? Dr. Matteo Lambertini: Yes, exactly. Knowing to be a BRCA carrier has a lot of implications from prevention to treatment to survivorship issues including reproductive counseling. And this is important not only for the patient that has been diagnosed with breast cancer but also for all the family members that will get tested and maybe identify with this sort of genetic alteration before diagnosis of cancer. Why this is important is because we have access to very effective preventive measures, a few examples: MRI screening, which starts at a very young age and normally young women don't have an effective screening strategy outside the BRCA field. Also, primary preventive measures, for example, risk-reducing surgery. These women are known to have a high risk of breast cancer and high risk of ovarian cancer. So the guidelines are suggesting to undergo risk-reducing salpingo-oophorectomy at a young age, so 35 to 40 years in BRCA1 carrier, 40 to 45 years in BRCA2 carrier. And also risk-reducing mastectomy should be discussed because it is a very effective way to prevent the occurrence of breast cancer. And in some situations, including the setting that we are talking about, so young women with breast cancer, BRCA carrier, also risk-reducing mastectomy has shown to improve overall survival.  On the other side, once diagnosed with breast cancer, nowadays knowing to be or not a BRCA carrier can make a difference in terms of treatment. We have PARP inhibitors in the early setting, in the adjuvant setting as well as in the metastatic setting. And in terms of survivorship implication, one of the critical aspects for young women is the oncofertility care which is even more complicated when we talk about BRCA carriers that are women candidates for gynecological surgery at a very young age. So this sort of counseling is even more complicated. Dr. Monty Pal: One of the other things, and this is subtle in your paper and I hope you don't mind me bringing it up, is the difference between BRCA1 and BRCA2. It really got me thinking about that because there are differences in phenotype and manifestation. Do you mind just expanding on that a little bit for the audience because I think that's a really important reminder that you brought up in the discussion? Dr. Matteo Lambertini: The difference between BRCA1 and BRCA2 carriers has been known that there are different phenotypes of breast cancer that are more often diagnosed in these two different populations. Normally BRCA1 carriers have a higher likelihood to develop a triple negative breast cancer as compared to BRCA2 carriers, more likely to develop a hormone receptor-positive HER2-negative disease. In this study, again, a specific population of young women with breast cancer, we have seen the same findings, mostly triple negative disease in BRCA1 carrier, mostly luminal-like disease in BRCA2 carrier. But what's novel or interesting from this study is to look also at the age at the time of diagnosis of this disease. And particularly in BRCA1 carriers, we should be sort of more careful about diagnosis of breast cancer and also other primary tumors including ovarian cancer because the risk of developing these malignancies is higher even at a younger age as compared to BRCA2 carriers. And this has implications also in the primary and secondary prevention that we were talking about earlier. Dr. Monty Pal: Oh, interesting. I guess the fundamental question then from your paper becomes, how do we get at the right patients for screening for BRCA1 and BRCA2? And I realize our audience here is largely oncologists who are going to be listening to this podcast, oncology providers, MDs, nurses, etc. But maybe speak for a moment to the general practitioner. Are there things that, for instance, a general practitioner should be looking for to say, “Wait a minute, this patient's high risk, we should consider BRCA1, BRCA2 testing or germline screening”? Dr. Matteo Lambertini: Yes, it's a very important question for the breast cancer community. After the updated ASCO guideline, the counseling is way easier because right now the age cutoff goes up to 65 years, meaning that all the patients diagnosed with breast cancer below the age of 65 years should be tested these days. And then above the age of 65, there are different criteria like triple-negative disease or family history. From a general practitioner standpoint, it's of course a bit more difficult, but knowing particularly the family history of the person that they have in front will be crucial to know if there are cases of breast cancer diagnosed at a young age, maybe triple-negative cases, knowing cases of ovarian cancer in first-degree relatives or pancreatic cancer in first-degree relatives, and of course cases of prostate cancer as well. So, I would say probably mostly the family side will be important from a general practitioner perspective.  From an oncology one, the other point that I think is important to stress also based on the data that we have shown in this publication is that having a case of breast cancer known to carry a BRCA pathogenic or likely pathogenic variant. It means that all the people around this case should get tested and if found to be BRCA carrier and healthy carrier, these people should also undergo the primary and secondary prevention strategies because this is very critical also to improve their outcomes and try to avoid the developing of breast or ovarian cancer, but also in the case of diagnosis of this disease, a diagnosis at an earlier stage, as we have seen in this paper. Dr. Monty Pal: Brilliant. I'm going to diverge from our list of questions here and close by asking a question that I have at the top of my mind. You're very young. I know our podcast listeners can't see you, but you're very, very young. Dr. Matteo Lambertini: Thank you. Thank you for that. Not so young but yeah. Dr. Monty Pal: You have nearly 300 papers. Your H-index is 67. You've already made these seminal contributions, as I outlined it from the outset, regarding fertility, regarding use of GnRH analogs, regarding pregnancy and breast cancer. What are you studying now? What are you really excited about right now that you're doing that you think might potentially be practice changing? Give us a little teaser. Dr. Matteo Lambertini: Yeah. Thanks a lot, Dr. Pal. Receiving this compliment from you is fantastic. So, thanks a lot for that. From my side, in terms of my research, I've been interested in the field of breast cancer in young women since the start of my training. I've had very good mentors from Italy, from Europe, from the U.S. I'm still interested in this field, so I think we still have a lot to learn to try to improve the care of young women with breast cancer. For example, the oncofertility care, which is something I worked a lot over the past years. Now with all the new treatment options, there's a sort of new chapter of oncofertility counseling. So, what's the impact of immunotherapy? What's the impact of the new targeted agents?  More on the genetic aspects, now we know that there's not only BRCA1 or BRCA2. There are a lot of other different genes that may increase the risk of breast cancer and other malignancies. And also for these genes, we really don't have a lot of evidence to counsel women on prognosis, treatment, prevention strategy. So we need to learn way more for this special patient population that are quite rare, and so we really need a multicenter academic effort to try to give some evidence in this field. Dr. Monty Pal: Yeah. It's tough because these are rare circumstances, but, you know, I think that you've done really well to sort of define some collective experiences that I think really define therapy. I mean, I just remember when I was in training 25 years ago, just reading through textbooks where all the experience around breast cancer and pregnancy was really just very sort of anecdotal almost, you know? And so it's great to see that the state of the science has moved forward.  Well, gosh, I really enjoyed our conversation today. I think your study really reminds us how powerful genetic information is in terms of improving outcomes. And, you know, hopefully this will lead some individuals to perhaps test more broadly in appropriate settings. So, thank you so much, Matteo, for joining us today with your fantastic insights on the ASCO Daily News Podcast. Dr. Matteo Lambertini: Thank you very much, Dr. Pal. It's a real pleasure. Dr. Monty Pal: And thanks to our listeners too. You'll find a link to Dr. Lambertini's study in the transcript of this episode. Finally, if you value the insights that you heard today on the ASCO Daily News Podcast, please rate, review, and subscribe wherever you get your podcasts. Thanks a ton. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Find out more about today's speakers:    Dr. Sumanta (Monty) Pal  @montypal  Dr. Matteo Lambertini @matteolambe   Follow ASCO on social media:     @ASCO on Twitter    ASCO on Bluesky   ASCO on Facebook     ASCO on LinkedIn     Disclosures:    Dr. Monty Pal:   Speakers' Bureau: MJH Life Sciences, IntrisiQ, Peerview  Research Funding (Inst.): Exelixis, Merck, Osel, Genentech, Crispr Therapeutics, Adicet Bio, ArsenalBio, Xencor, Miyarsian Pharmaceutical  Travel, Accommodations, Expenses: Crispr Therapeutics, Ipsen, Exelixis  Dr. Matteo Lambertini: Consulting or Advisory Role: Roche, Novartis, Lilly, AstraZeneca, Pfizer, MSD, Exact Sciences, Gilead Sciences, Seagen, Menarini, Nordic Pharma Speakers' Bureau: Takeda, Roche, Lilly, Novartis, Pfizer, Sandoz, Ipsen, Knight Therapeutics, Libbs, Daiichi Sankyo, Gilead Sciences, AstraZeneca, Menarini, AstraZeneca, Menarini Research Funding (Inst.): Gilead Sciences Travel, Accommodations, Expenses: Gilead Sciences, Daiichi Sankyo Europe GmbH, Roche

Recently the Endocrine Society held its 12th annual Type 1 Diabetes Fellows Series program, which combines comprehensive education on type 1 diabetes with career development opportunities to build knowledge, practical skills, and a lasting network of colleagues. For this episode, host Aaron Lohr talks with Desmond Schatz, MD, medical director of the Diabetes Institute and director of the Clinical Research Center at the University of Florida. Dr. Schatz gave a talk at the fellows series program titled, “Immunotherapies for Type 1 Diabetes: Need for Early Detection and Screening.” This year’s fellows series program and this episode were made possible by the support of Abbott Diabetes Care, CeQur Corp., Dexcom Inc., Insulet Corp., Breakthrough T1D (formerly the Juvenile Diabetes Research Foundation), Lilly USA, Mankind Pharma Limited, Medtronic Inc., Novo Nordisk Inc., and Vertex Pharmaceuticals Inc. Show notes are available at https://www.endocrine.org/podcast/enp103 — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

Katie Henry has seen some things. From nonprofit bootstraps to Big Pharma boardrooms, she's been inside the machine—and still believes we can fix it. We go deep on her winding road from folding sweaters at J.Crew to launching a vibrator-based advocacy campaign that accidentally changed the sexual health narrative in breast cancer.Katie doesn't pull punches. She's a born problem solver with zero tolerance for pink fluff and performative empathy. We talk survivor semantics, band camp trauma, nonprofit burnout, and why “Didi” is the grandparent alter ego you never saw coming.She's Murphy Brown with a marimba. Veronica Sawyer in pharma. Carla Tortelli with an oncology Rolodex. And she still calls herself a learner.This is one of the most honest, hilarious, and refreshingly real conversations I've had. Period.RELATED LINKS:Katie Henry on LinkedInKatie Henry on ResearchGateLiving Beyond Breast CancerNational Breast Cancer CoalitionFEEDBACK:Like this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Episode Summary Bill and Pete get personal about a shared health detour—early-detected prostate cancer—and how “health meets wealth” shows up in real life. They unpack the emotional and practical steps (baselines, deltas, options, decisions), then pivot to Pete's new niche venture: Certified Exit Planning Advisor (CEPA) work and the launch of The Confident Exit podcast for business owners. Time-Stamped Show Notes 00:00 – Welcome & context Bill opens the show and explains they've been on a brief hiatus; Pete joins remotely from San Francisco (actual hotel room, not a virtual background). 00:43 – Where's Pete? Pete's calling in from San Francisco, CA; quick banter about travel and being “alongside on screen.” 01:13 – Why the hiatus It's “been a minute.” They tee up a candid health conversation and a new podcast announcement. 01:30 – Health Meets Wealth (Chapter call-back) Bill frames the pause through the lens of the book's “health meets wealth” theme. 01:39 – Pete's health journey (early detection) A year-long series of tests escalates from “yellow flag” to “red flags.” Diagnosis: prostate cancer, caught early. Pete opts for surgery (early May), good recovery, and gratitude for proactive care and skilled medical teams. 03:18 – Bill's parallel path Family history heightens vigilance. Bill tracks PSA trend (delta) even while within “normal,” leading to MRI → biopsy. 04:34 – Valentine's Day twist: both brothers end up getting biopsies the same day—unknowingly. 04:45 – Diagnosis details & options Bill's Gleason score is a bit lower; he explores alternatives (incl. TULSA-PRO) and clinical trials comparing it to standard surgery. Randomized to surgery; undergoes laparoscopic removal at end of July. Two months post-op at recording—healing well. 06:32 – The headspace & decision process Choosing among credible options; balancing personal values, family impact, and medical clarity. Pete's approach: execute step-by-step (don't over-project), while noting loved ones may process differently. 10:24 – September awareness It's Prostate Cancer Awareness Month; heightened appreciation this year. 10:36 – Community support: Blue Ribbon Soirée involvement becomes part of their ongoing advocacy. 10:51 – “Snakes on the runway” Bill's milestone moments: heart scare at 50; prostate surgery at 60. The “snake in the grass” metaphor from the book—find it, step over it, deal with it—and the humor (what happens at 70/80?). 11:35 – The big takeaway: baselines Be proactive: get baseline labs and track the delta annually. You owe it to yourself and your tribe (family, partners, employees). Tie-in to CYA360 themes: key-person health risk to a business. 12:54 – Bites & Insights + “Glimpse of the Future” At Horizon lunches, they use the handout to project yourself—and your tribe—forward in 5-year increments. Planning for your future self is easier when you visualize loved ones aging too. 15:28 – Cognitive risk in later years Stats awareness (e.g., dementia/Alzheimer's prevalence in the 80s) reminds listeners to pre-plan for wealth protection as cognition can decline—even for once-meticulous stewards. 16:26 – Making the future “feel real” Bill's example of projecting his daughter's milestones to make his future tangible (weddings, timing, costs). 17:16 – Time flies 59½ used to feel far away; now it's in view or in the rear-view. Keep thinking ahead; stay systematic about savings, investing, and health check-ups. 18:02 – Programming note: Pete's new focus This is Pete's last regular Runway Decade episode for a while. He's leaning into exit planning (CEPA) with a new podcast: The Confident Exit. 18:29 – Why exit planning now Background: client exits, Horizon's own acquisitions, and a maturing ecosystem (valuation, legal, tax). Show format returns to guests—experts surrounding business owners. 20:08 – Where to find it HorizonFG.com → Business Exit Planning page; podcast hosted there and on Apple/Libsyn. Three episodes recorded and rolling out. 20:34 – The niche Just like Runway Decade targets 50-somethings, The Confident Exit targets owners with most of their wealth locked in one illiquid asset—the business. Goal: help monetize and design “what's next.” 21:36 – Wrap & contacts Bill: bbush@horizonfg.com, RunwayDecade.com contact box, or HorizonFG.com. Pete: pbush@horizonfg.com; follow his exit-planning articles and podcast clips on LinkedIn and Horizon's site. Safe travels & sign-off. Key Takeaways Early detection saves futures: Get annual baselines and watch the trend (delta), not just “normal ranges.” Decisions are personal: Multiple credible pathways (surgery, radiation, ablation/TULSA-PRO, etc.); choose with your values, facts, and family in mind. Health ↔ wealth: Your wellbeing is a key-person risk to your family and business; plan accordingly. Future-you planning: Use “glimpse of the future” to make timelines, costs, and care needs real. New resource for owners: Check out Pete's The Confident Exit for valuation, legal, tax, and deal-prep insights. Pull Quotes / Sound Bites “Get a baseline on everything—and track the delta.” “Step over the snake: find the problem, choose the path, execute.” “Life goes fast—think ahead: health and wealth both reward early action.” Resources & Links Runway Decade site & contact: RunwayDecade.com Horizon Financial Group: HorizonFG.com → Business Exit Planning The Confident Exit podcast (Pete) — also on Apple/Libsyn Email: Bill — bbush@horizonfg.com | Pete — pbush@horizonfg.com Disclosure The views depicted in this material are for information purposes only and are not necessarily those of Cetera Advisors LLC. They should not be considered specific advice or recommendations for any individual. Neither Cetera Advisors LLC nor any of its representatives may give legal or tax advice. Bill Bush, Andy Bush, and Pete Bush are registered representatives offering securities and advisory services through Cetera Advisors LLC, member FINRA/SIPC, a broker-dealer, and registered investment advisor. Cetera is under separate ownership from any other named entity. 15015 Jamestown Boulevard, Suite 100, Baton Rouge, Louisiana, 70810.

CapeTalk’s Sara-Jayne Makwala King is joined on Weekend Breakfast by Philippa Brinkman, Spokesperson for ILoveBoobies. Listen live on Primedia+ Saturdays and Sundays between 07:00 and 10:00am (SA Time) to Weekend Breakfast with Sara-Jayne Makwala-King broadcast on CapeTalk https://buff.ly/NnFM3Nk For more from the show go to https://buff.ly/AgPbZi9 or find all the catch-up podcasts here https://buff.ly/j1EhEkZ Subscribe to the CapeTalk Daily and Weekly Newsletters https://buff.ly/sbvVZD5 Follow us on social media: CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567 See omnystudio.com/listener for privacy information.

Join us as we sit down with Marisa Peters, a colorectal cancer survivor and passionate advocate, to hear her inspiring journey through diagnosis, treatment, and life after cancer. Marisa shares how she navigated the challenges of managing a career, raising a family, and adapting to the evolving landscape of cancer care. This episode offers heartfelt insights for both patients and caregivers on staying resilient, finding support, and embracing life beyond cancer. For more resources, click the links below.  https://beseen.care/  https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening  https://www.instagram.com/fromcarpoolstochemo/  https://wvmountainsofhope.org/  https://fightcolorectalcancer.org/ 

Calandrea Carter and Alauna Marable sit with breast cancer survivor Tralee Hale and her son, Kelee Ringo of the Philadelphia Eagles. They share their journey of resilience, love, and advocacy during Tralee's triple-negative breast cancer diagnosis and the importance of early detection. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Are you taking too many medications? Your blood may soon have tiny robots flowing through it. We can detect more cases of Alzheimer's disease, so why aren't we? A new fix for carbon monoxide poisoning. Learn More: https://radiohealthjournal.org/medical-notes-youre-taking-too-many-medications-why-early-detection-for-alzheimers-disease-isnt-working-and-a-better-treatment-for-carbon-monoxide-poisoning Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. Joseph Dankoff of Summa Health discusses ExactVu, a new technology for prostate screening.

In this episode, host Chris Duffin sits down with the legendary Clark Bartram—Marine veteran, National Fitness Hall of Fame inductee, and founder of the Maximized Man Elite program. Known as America's most trusted fitness professional, Clark has dedicated his life to inspiring men to reclaim their vitality, strength, and purpose—naturally and sustainably. Clark Bartram's journey in men's health and fitness is nothing short of remarkable. Once a U.S. Marine, Clark transformed his discipline and passion into a decades-spanning career—earning recognition as “America's most trusted fitness professional.” He's inspired millions through books, TV appearances, and elite coaching, notably with his Maximized Man Elite program, guiding men over 40 to reclaim vitality and strength naturally. At age 61, Clark faced a new test: a diagnosis of prostate cancer despite his peak condition. Rather than let it stop him, Clark became an advocate, founding the nonprofit “Check It Like a Man” to promote early screening and awareness. Clark Bartram: https://clarkbartramsystems.com Instagram: @clarkbartram   This episode of the ARCHITECT of RESILIENCE podcast is available on Apple, Spotify & YouTube, and is sponsored by: @marekhealth : Performance. Longevity. Optimization.

What happens when you hand a mic to the most extroverted, uncensored Gen Z career coach in New York? You get Olivia Battinelli—adjunct professor, student advisor, mentor, speaker, and unfiltered truth-teller on everything from invisible illness to resume crimes.We talked about growing up Jewish-Italian in Westchester, surviving the Big Four's corporate Kool-Aid, and quitting a job after 7 months because the shower goals weren't working out. She runs NYU Steinhardt's internship program by day, roasts Takis and “rate my professor” trolls by night, and somehow makes room for maple syrup takes, career coaching, and a boyfriend named Dom who sounds like a supporting character from The Sopranos.She teaches kids how to talk to humans. She's allergic to BS. And she might be the most Alexis Rose-meets-Maeve Wiley-mashup ever dropped into your feed. Welcome to her first podcast interview. It's pure gold.RELATED LINKS:Olivia Battinelli on LinkedInOlivia's Liv It Up Coaching WebsiteOlivia on InstagramNYU Steinhardt Faculty PageFEEDBACK:Like this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Sophie Sargent walked into the studio already owning the mic. A pandemic-era media rebel raised in New Hampshire, trained in Homeland Security (yep), and shaped by rejection, she's built a career out of DM'ing her way into rooms and then owning them. At 25, she's juggling chronic illness, chronic overachievement, and a generation that gets dismissed before it even speaks.We talk Lyme disease, Lyme denial, and the healthcare gaslighting that comes when you “look fine” but your body says otherwise. We dive into rejection as a career accelerant, mental health as content porn, and what it means to chase purpose without sacrificing identity. Sophie's a former morning radio host, country music interviewer, and Boston-based creator with a real voice—and she uses it.No fake podcast voice. No daddy-daughter moment. Just two loudmouths from different planets figuring out what it means to be seen, believed, and taken seriously in a system designed to do the opposite.Spoiler: She's smarter than I was at 25. And she'll probably be your boss someday.RELATED LINKSSophie on InstagramSophie on YouTubeSophie on LinkedInMedium article: “Redefining Rejection”See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode, we sit down with Teresa Richardson, Executive Director of Help The Fight, and Stacey Rife, Manager of Imaging Operations at WellSpan York Hospital, to discuss the vital resources available to individuals fighting breast cancer in our community. Help The Fight is a powerful grassroots organization offering a hand up—not a handout—to those undergoing breast cancer treatment and those in need of essential screening services.We explore how the organization supports local patients in Lancaster and surrounding counties and highlight the life-saving impact of early detection. Stacey also shares exciting news about WellSpan's Mobile Mammography unit—bringing accessible, high-quality breast cancer screening directly to neighborhoods that need it most.Tune in to hear how these passionate women and their organizations are working together to make a real difference, one screening at a time.

  “One powerful, overlooked aspect of colorectal cancer survivorship is the emotional and identity transformation that our survivors undergo—and really how little space is given in the clinical arena for that. No one really talks about this ‘invisible recovery.' Facing mortality can lead to prolonged changes is values, relationships, and life goals. And these experiences aren't captured in lab results or imaging scans, but they really shape how survivors live, love, and heal and continue with their lives,” ONS member Kris Mathey, DNP, APRN-CNP, AOCNP®, gastrointestinal medical oncology nurse practitioner at The James Cancer Hospital of The Ohio State University Wexner Medical Center in Columbus, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about colorectal cancer survivorship. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by September 12, 2026. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learner will report an increase is knowledge related to colorectal cancer survivorship nursing considerations. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Episode 374: Colorectal Cancer Treatment Considerations for Nurses Episode 370: Colorectal Cancer Screening, Early Detection, and Disparities Episode 201: Which Survivorship Care Model Is Right for Your Patient? Episode 153: Metastatic Colorectal Cancer Has More Treatment Options Than Ever Before ONS Voice articles: Genetic Disorder Reference Sheet: Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) Here Are the Current Nutrition and Physical Activity Recommendations for Cancer Survivors ONS course: Essentials in Survivorship Care for the Advanced Practice Provider Clinical Journal of Oncology Nursing article: Closing the Gaps: Addressing the Unmet Needs of Cancer Survivors Oncology Nursing Forum articles: Symptom Occurrence, Frequency, and Severity During Acute Colorectal Cancer Survivorship The Relationship Between Colorectal Cancer Survivors' Positive Psychology, Symptom Characteristics, and Prior Trauma During Acute Cancer Survivorship ONS Survivorship Care Plan Huddle Card ONS Learning Libraries: Colorectal cancer Survivorship Academy of Oncology Nurse and Patient Navigators American Cancer Society National Colorectal Cancer Roundtable Colorectal Cancer Alliance Colorectal Cancer Resource and Action Network Fight Colorectal Cancer Resource Library Livestrong at the YMCA Pan Ohio Hope Ride To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode “As of the most recent data, more than 1.5 million people in the United States are living as colorectal cancer survivors. So this includes not only those who are currently undergoing active cancer treatment but also those who have completed treatment and ultimately are hopefully in remission. Just a reminder that colon cancer is the third most commonly diagnosed cancer in the United States and it's the fourth leading cause of cancer-related deaths.” TS 1:53 “Our colorectal cancer survivors may have significant barriers when receiving this comprehensive survivorship care, and these challenges can affect not only their physical recovery but their emotional well-being and, ultimately, their long-term health outcomes. We as oncology nurses do play a pivotal role in identifying and addressing these barriers. So these can include fragmented care. Who's caring for these patients? That care coordination between the oncologist and the oncology team and then the primary care providers and team. Limited access—so our patients that may have geographic limited access or also financial- or insurance-related obstacles to follow-up services.” TS 9:10 “Our nurses can also facilitate the communication between specialists and primary care providers, so making sure that we're sending records, keeping those lines of communications open. Also, nurses can provide that psychosocial support, so our screening for distress and also advocating and supporting for referral to counseling or support groups for a patient. Nurses can also act as navigators to guide these patients through complex care systems.” TS 11:21 “Some of the recommended changes—nutrition—enhancing and emphasizing fruits, vegetables, that colorful plate, with whole grains. Limit those red and processed meats, and reduce sugary drinks and alcohol. I know we will all have those patients who have read things or cancer myths about, ‘Oh, cancer feeds on sugar, so I shouldn't drink anything or eat anything with sugar,' and maybe addressing that, just really emphasizing the well-rounded meals.” TS 19:57 “When we think about [ourselves], ‘Well, I don't have an implicit bias,' but we may not think about what that is. Some common preconceived assumptions are that survivorship equals a cure. And this assumption may overlook that chronic symptoms or those late effects and emotional needs of long-term survivors. So knowing that when a patient is coming to us on surveillance, they may be cured; they may not have active cancer, but they're still dealing with some of those chronic symptoms—and acknowledging that.” TS 30:37 “There's an assumption that an ostomy equals poor quality of life, and this may stigmatize patients and discourage open conversations about adaptation and support. A couple weeks ago, I volunteered at the Pan Ohio Hope Ride, which is with the American Cancer Society, and several states have a ride that's similar. And there was a patient riding, and I could tell over his jersey that he had an ostomy bag underneath that. And I just looked at him and I thought, ‘That's amazing. You are still functioning, still living, still riding a bike throughout the entire state of Ohio with an ostomy.' So he's still having that good quality of life. That doesn't stop him from living.” TS 31:39

Welcome to this episode of Ditch the Lab Coat, hosted by Dr. Mark Bonta—a show where curiosity meets science and skepticism, all in the name of practical healthcare innovation.This week, we tackle a problem plaguing healthcare systems across Canada (and beyond): the painfully long wait times to see a dermatologist, especially when it comes to skin cancer. Our guest is Mike Druhan, President of Dermatology Services at MedX Health. Mike is on a mission to save lives by closing the gap between a suspicious mole and a potentially life-saving diagnosis.Together, Dr. Bonta and Mike explore the bottlenecks of Canadian healthcare, the trust required for new technologies to be accepted, and the real-world journey of bringing evidence-based digital solutions—like secure skin imaging and teledermatology—to market. You'll hear the candid realities behind innovation in medicine, the hurdles of building clinician confidence, and why access—not just technology—can be the biggest lifesaver of all.Plus, Mike shares eye-opening stories from the field, including how a routine golf outing and a sharp eye led to an early melanoma diagnosis that made all the difference for a patient. If you've ever wondered why game-changing ideas in medicine can take so long to become reality—or how technology can help us fight diseases hiding in plain sight—this conversation is for you.Plug in, enjoy, and get ready for a deep dive into the art and science of making innovation practical, trustworthy, and patient-centered.Episode HighlightsTrust Drives Healthcare Adoption — Healthcare innovation only moves as fast as stakeholders trust new systems and tech, making trust central to successful adoption.Early Detection Saves Lives — Catching skin cancer at the earliest stage dramatically improves outcomes and reduces treatment costs and patient suffering.Access Is a Critical Barrier — Long wait times to see specialists like dermatologists can be deadly; smart solutions must address these systemic access issues.Tech Complements, Not Replaces — Innovative tools are designed to support, not substitute, specialists—helping prioritize urgent cases and manage the patient queue.Design for Clinical Reality — Successful tools require clinician input, regulatory compliance, and clear workflow integration to earn real-world adoption.Iterate with Frontline Feedback — Regular collaboration with diverse healthcare professionals refines questions, workflows, and builds essential clinical buy-in.Evidence First, Hype Later — Robust evidence and pilot programs—rather than flashy promises—pave the path for credible healthcare innovation.AI Is an Assistant, Not Judge — AI is best used as a double-check for clinicians, enhancing accuracy but not replacing expert human decision-making.Economic Incentives Matter — Insurers and employers increasingly see the financial sense in proactive screening and early intervention for high-risk groups.Human Factor Still Critical — Even with tech, “right place, right time” expert intervention can make the difference between early cure and late-stage tragedy.Episode Timestamp03:59 – Canadian Healthcare Access Challenges 09:40 – Dermatology Digital Patient Platform Development 13:25 – Trust Barriers in Healthcare Innovation 15:57 – Dermatology Investment Collaboration Insights 19:05 – Prioritizing Urgent Pathology Reports 22:54 – Dermatology: Ownership and Patient Insights 24:19 – Dynamic Approach to Skin Cancer Tracking 28:38 – Early Detection through Stool Testing 32:56 – Canada's Dermatology Shortage and Insurance Solutions 33:38 – Predictive Analytics in Workplace Safety 37:07 – AI-Assisted Skin Cancer Detection 42:15 – Human Error vs. AI Expectations 45:47 – AI Enhancing Medical Diagnostics 46:46 – Trusting Emerging Healthcare Technologies DISCLAMER >>>>>>    The Ditch Lab Coat podcast serves solely for general informational purposes and does not serve as a substitute for professional medical services such as medicine or nursing. It does not establish a doctor/patient relationship, and the use of information from the podcast or linked materials is at the user's own risk. The content does not aim to replace professional medical advice, diagnosis, or treatment, and users should promptly seek guidance from healthcare professionals for any medical conditions.   >>>>>> The expressed opinions belong solely to the hosts and guests, and they do not necessarily reflect the views or opinions of the Hospitals, Clinics, Universities, or any other organization associated with the host or guests.    Disclosures: Ditch The Lab Coat podcast is produced by (Podkind.co) and is independent of Dr. Bonta's teaching and research roles at McMaster University, Temerty Faculty of Medicine and Queens University. 

This episode is sponsored by Invivyd, Inc.Marc Elia is a biotech investor, the Chairman of the Board at Invivyd, and a Long COVID patient who decided to challenge the system while still stuck inside it. He's not here for corporate platitudes, regulatory shoulder shrugs, or vaccine-era gaslighting. This is not a conversation about politics, but it's about power and choice and the right to receive care and treatment no matter your condition.In this episode, we cover everything from broken clinical pathways to meme coins and the eternal shame of being old enough to remember Eastern Airlines. Marc talks about what it means to build tools instead of just complaining, what Long COVID has done to his body and his patience, and why the illusion of “choice” in healthcare is a luxury most patients don't have.This conversation doesn't ask for empathy. It demands it.RELATED LINKSMarc Elia on LinkedInInvivyd Company SiteMarc's Bio at InvivydFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Alzheimer's Disease Early Diagnosis and Management Evaluation and Credit:  https://www.surveymonkey.com/r/medchat82   Target Audience             This activity is targeted toward primary care physicians and advanced providers. Statement of Need A special report of Alzheimer's Disease Facts and Figures published in 2017, indicated 4 out of 5 Americans would want to know if they had Alzheimer's disease before it impacted their life. With the aging population the incidence of Alzheimer's is growing, according to the Alzheimer's Association over 7 million Americans are living with AD. This program will focus on screening and dx of AD in the early stages especially in pc offices, where patients will first present with cognitive symptoms. Additionally, this podcast will highlight the new blood biomarker test recently approved and its indications. Objectives  Differentiate between normal cognitive aging, mild cognitive impairment and early-stage Alzheimer's disease. Identify appropriate cognitive screening tools for use in primary care and their role in the early identification of Alzheimer's disease. Explain the mechanism and clinical relevance of blood-based biomarkers in the diagnosis of Alzheimer's disease, including the current guidelines and emerging practices. ModeratorRachel Hart, D.O. Geriatric Medicine Physician Memory and Cognitive Disorders Specialist Norton Neuroscience Institute Memory Center SpeakerGreg E. Cooper, M.D., Ph.D. Chief, Adult Neurology Medical Director, Memory Center Norton Neuroscience Institute   Planner Disclosure  The planners of this activity do not have any relevant financial relationships with ineligible companies to disclose. Moderator and Speaker DisclosureThe moderator, Gregory Cooper, M.D., Ph.D., discloses relevant financial relationships with Eli Lilly and Eisai (research). The speaker, Rachel Hart, D.O., discloses a relevant financial relationship with Eli Lilly (faculty).  All relevant financial relationships have been successfully mitigated. Commercial Support  There was no commercial support for this activity.  Physician CreditsAccreditation Norton Healthcare is accredited by the Kentucky Medical Association to provide continuing medical education for physicians. Designation Norton Healthcare designates this enduring material for a maximum of .50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nursing Credits Norton Healthcare Institute for Education and Development is approved as a provider of nursing continuing professional development by the South Carolina Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation. This continuing professional development activity has been approved for 0.50 ANCC CE contact hours. In order for nursing participants to obtain credits, they must claim attendance by attesting to the number of hours in attendance.   For more information related to nursing credits, contact Sally Sturgeon, DNP, RN, SANE-A, AFN-BC at (502) 446-5889 or sally.sturgeon@nortonhealthcare.org.   Resources for Additional Study/ReferencesAmerican Perspectives on Early Detection of Alzheimer's Disease in the Era of Treatment https://www.alz.org/alzheimers-dementia/facts-figures   Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care https://pubmed.ncbi.nlm.nih.gov/39068545/   Date of Original Release | Sept. 2025; Information is current as of the time of recording.  Course Termination Date | Sept. 2028 Contact Information | Center for Continuing Medical Education; (502) 446-5955 or cme@nortonhealthcare.org Also listen to Norton Healthcare's podcast Stronger After Stroke. This podcast, produced by the Norton Neuroscience Institute, discusses difficult topics, answers frequently asked questions and provides survivor stories that provide hope. Norton Healthcare, a not for profit health care system, is a leader in serving adult and pediatric patients throughout Greater Louisville, Southern Indiana, the commonwealth of Kentucky and beyond. More information about Norton Healthcare is available at NortonHealthcare.com.

In this episode, Dr. Tom Beer, Chief Medical Officer for Multi-Cancer Early Detection at Exact Sciences, shares how blood-based screening could identify dozens of cancers earlier, the steps for thoughtful clinical implementation, and the potential to significantly reduce late-stage cancer diagnoses and mortality.This episode is sponsored by Exact Sciences.

After years of carrying the weight of lead, Shannon and Cooper find a path out from under the darkness and into the sunlight.LEAD: how this story ends is up to us is an audio docudrama series that tells the true story of one child, his mysterious lead poisoning, and his mother's unwavering fight to keep him safe. A true story written by Shannon Burkett. Directed by Alan Taylor. Starring Merritt Wever, Alessandro Nivola, Cynthia Nixon, and Cooper Burkett.Lead was produced by Shannon Burkett. Co-produced by Jenny Maguire. Featuring Amy Acker, Tom Butler, Dennis T. Carnegie, James Carpinello, Geneva Carr, Dann Fink, Alice Kris, Adriane Lenox, Katie O'Sullivan, Greg Pirenti, Armando Riesco, Shirley Rumierk, Thom Sesma, and Lana Young. Music by Peter Salett. “Joy In Resistance” written by Abena Koomson-Davis and performed by Resistance Revival Chorus. Casting by Alaine Alldaffer and Lisa Donadio. Sound Design by Andy Kris. Recording Engineer Krissopher Chevannes.For corresponding visuals and more information on how to protect children from lead exposure please go to https://endleadpoisoning.org.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In 1964, the future for children born with Cystic Fibrosis was grim - most faced a life cut tragically short. Today, the majority of people living with CF in the UK are adults, a testament to extraordinary medical progress.We meet Annabelle who lives with Cystic Fibrosis, and once believed she might not see her 18th birthday. And we hear from Dr Imogen Felton, a respiratory consultant at Royal Brompton Hospital, with expertise in cystic fibrosis, who tells us about the therapies crucial to this extended prognosis. The EDITH trial (Early Detection using Information Technology in Health) is testing how AI can help radiologists identify breast cancer at an earlier stage, transforming the future of diagnosis. We speak to Professor Sian Taylor-Philips, Professor of Population Health at the University of Warwick and co-leader of the trial.In 2024, participation in Run Clubs across the UK surged by 64%. But does running in a group lead to better performance? To find out, James laces up for a jog around Hyde Park with the Monday Mood Booster Run Club and speaks with Arran Davis, a postdoctoral researcher at the University of Oxford, who's exploring the links between social interaction and physical activity.Presenter: James Gallagher Producers: Debbie Kilbride, Minnie Harrop & Tom Bonnett Editor: Ilan Goodman Production coordinator: Ishmael Soriano This episode was produced in partnership with The Open University.

In this deeply personal episode, Dr. Ashley Joves is joined by her husband, Dr. Brian Joves, just six days after his surgery for oral squamous cell carcinoma. Together, they share the emotional rollercoaster of the past month—from Ashley's gut instinct and relentless advocacy to the medical whirlwind that followed.Brian bravely walks listeners through his diagnosis, surgery, and the critical importance of early detection, while Ashley reflects on the weight of being a caregiver, mother, and dental professional during the most frightening chapter of their lives.This is more than a cancer story. It's a lesson in listening to your instincts, advocating fiercely, loving deeply, and the strength of community when everything feels uncertain.What You'll Learn in This Episode:How a dentist's eye and a wife's intuition saved a lifeThe emotional toll and resilience required during a health crisisWhy oral cancer screenings matter—every patient, every timeHow vulnerability can deepen connection and unlock purposeThe importance of being your own advocate in a system that doesn't always move fast enoughThe value of community in medicine and entrepreneurshipNotable Quotes:"You have to be your own advocate. I don't care who you are or how you think the system works—sometimes it doesn't work for you." – Dr. Ashley Joves"You can do all the right things… and still get cancer. That's why we have to screen. Every patient. Every time." – Dr. Brian Joves"Fear is not a stop sign—it's an invitation to act." – Dr. Ashley JovesA Personal Note from Ashley & Brian:To our incredible community—thank you. Your messages, prayers, and support have carried us through the hardest month of our lives. We hope this episode empowers you to listen to your gut, screen with intention, and hold your loved ones close.

The deficits from the lead poisoning continue to intensify, Shannon channels her anger and grief into holding the people who hurt her son responsible.LEAD how this story ends is up to us is a true story written and produced by Shannon Burkett. Co-produced by Jenny Maguire. Directed by Alan Taylor. Starring Merritt Wever, Alessandro Nivola, Cynthia Nixon, and Cooper Burkett.EP4 features Eboni Booth, Sasha Eden, Kevin Kane, April Matthis, Alysia Reiner, and Mandy Siegfried. Casting by Alaine Alldaffer and Lisa Donadio. Music by Peter Salett. Sound Design by Andy Kris. Recording Engineer Krissopher Chevannes.For corresponding visuals and more information on how to protect children from lead exposure please go to https://endleadpoisoning.org.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The effects of the neurotoxin are taking their toll on Cooper as Shannon desperately tries to navigate the severity of their new reality.LEAD how this story ends is up to us is a true story written and produced by Shannon Burkett. Co-produced by Jenny Maguire. Directed by Alan Taylor. Starring Merritt Wever, Alessandro Nivola, Cynthia Nixon, and Cooper Burkett.E43 features Jenny Maguire, JD Mollison, Laith Nakli, Deirdre O'Connell, Carolyn Baeumler, Zach Shaffer, and Monique Woodley. Casting by Alaine Alldaffer and Lisa Donadio. Music by Peter Salett. Sound Design by Andy Kris. Recording Engineer Krissopher Chevannes.For corresponding visuals and more information on how to protect children from lead exposure please go to https://endleadpoisoning.org.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

As the lead wreaks havoc on Cooper's development, Shannon searches for answers. Desperate to get a handle on what was happening to her son, she grabs onto a lifeboat - nursing school. Andy tries to piece together the past to make sense of the present.LEAD how this story ends is up to us is a true story written and produced by Shannon Burkett. Co-produced by Jenny Maguire. Directed by Alan Taylor. Starring Merritt Wever, Alessandro Nivola, Cynthia Nixon, and Cooper BurkettEP2 features Keith Nobbs and Frank Wood. Music by Peter Salett. Sound Design by Andy Kris. Recording Engineer Krissopher Chevannes. Casting by Alaine Alldaffer and Lisa Donadio.For corresponding visuals and more information on how to protect children from lead exposure please go to https://endleadpoisoning.org.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.